Long-read RNA-seq atlas of novel microglia isoforms elucidates disease-associated genetic regulation of splicing

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was supported by the following National Institutes of Health grants: T.R., J.H, E.B., D.M., E.C. and B.Z.M: NIA U01-AG058635, NIA R21-AG063130, NIA R01-AG054005, NIA U01-AG068880, NIA RF1-AG065926, NIA R56-AG055824, NIA P30-AG066514, NINDS U54-NS123743, and NINDS R01-NS116006. P.R., R.K., B.Z., S.P.K, S.A., Z.S., G.E.H. and J.F.F.: NIA U01-AG058635, NIA R01-AG067025, NIA R01-AG082185, NIA R01-AG050986, NIA R01-AG065582, NIMH R01-MH125246, and NINDS U01-NS125580. A.M.G., A.M., and A.G.E.: NIA U01-AG058635.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics committee/IRB of Mount Sinai gave ethical approval for this work. Ethics committee/IRB of James J. Peters Department of Veterans Affairs Medical Center gave ethical approval for this work. Ethics committee/IRB of Rush Alzheimer's Disease Center gave ethical approval for this work. Ethics committee/IRB of the VU University Medical Center, Amsterdam, gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes